UBS Group AG grew its stake in Relx Plc (NYSE:RELX – Free Report) by 151.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 134,348 shares of the technology company’s stock after purchasing an additional 80,989 shares during the period. UBS Group AG’s holdings in Relx were worth $5,430,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Huntington National Bank lifted its position in Relx by 5.1% during the third quarter. Huntington National Bank now owns 5,150 shares of the technology company’s stock worth $246,000 after buying an additional 250 shares in the last quarter. Concurrent Investment Advisors LLC grew its holdings in Relx by 3.2% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 8,039 shares of the technology company’s stock valued at $384,000 after buying an additional 252 shares in the last quarter. Bridgewater Advisors Inc. increased its stake in shares of Relx by 2.5% in the 4th quarter. Bridgewater Advisors Inc. now owns 11,084 shares of the technology company’s stock worth $447,000 after acquiring an additional 267 shares during the last quarter. Geneos Wealth Management Inc. raised its holdings in shares of Relx by 7.4% during the 2nd quarter. Geneos Wealth Management Inc. now owns 4,007 shares of the technology company’s stock worth $218,000 after acquiring an additional 275 shares during the period. Finally, Horizon Investments LLC raised its holdings in shares of Relx by 23.0% during the 3rd quarter. Horizon Investments LLC now owns 1,517 shares of the technology company’s stock worth $72,000 after acquiring an additional 284 shares during the period. Institutional investors and hedge funds own 15.02% of the company’s stock.
Relx Trading Up 0.0%
Shares of Relx stock opened at $33.58 on Thursday. The company has a quick ratio of 0.44, a current ratio of 0.49 and a debt-to-equity ratio of 2.38. Relx Plc has a 52 week low of $27.57 and a 52 week high of $56.33. The business’s fifty day simple moving average is $34.24 and its 200-day simple moving average is $36.89.
Analysts Set New Price Targets
Check Out Our Latest Analysis on RELX
About Relx
RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.
RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.
See Also
- Five stocks we like better than Relx
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.
